Tau is essential to β-amyloid-induced neurotoxicity
Open accessThe DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Abstract
Senile plaques and neurofibrillary tangles, the two hallmark lesions of Alzheimer's disease, are the results of the pathological deposition of proteins normally present throughout the brain. Senile plaques are extracellular deposits of fibrillar β-amyloid peptide (Aβ); neurofibrillary tangles represent intracellular bundles of self-assembled hyperphosphorylated tau proteins. Although these two lesions are often present in the same brain areas, a mechanistic link between them has yet to be established. In the present study, we analyzed whether tau plays a key role in fibrillar Aβ-induced neurite degeneration in central neurons. Cultured hippocampal neurons obtained from wild-type, tau knockout, and human tau transgenic mice were treated with fibrillar Aβ. Morphological analysis indicated that neurons expressing either mouse or human tau proteins degenerated in the presence of Aβ. On the other hand, tau-depleted neurons showed no signs of degeneration in the presence of Aβ. These results provide direct evidence supporting a key role for tau in the mechanisms leading to Aβ-induced neurodegeneration in the central nervous system. In addition, the analysis of the composition of the cytoskeleton of tau-depleted neurons suggested that the formation of more dynamic microtubules might confer resistance to Aβ-mediated neurodegeneration.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These observations support the idea that Aβ and Tau act together and that Aβ is upstream of Tau [114,115], positioning Aβ as the initiator and Tau as the executor in the pathogenetic process [116].”
From Neuron Loss in Alzheimer’s Disease: Translation in Transgenic Mouse Models (2020) · cites this paper as [115]
In the citing paper
“Indeed, Tau has been implicated in the synaptotoxicity induced by Aβ exposure [102].”
From The new genetic landscape of Alzheimer’s disease: from amyloid cascade to genetically driven synaptic failure hypothesis? (2019) · cites this paper as [102]
In the citing paper
“Thus, cultured neurons from tau knockout (Tau−/−) mice are not susceptible to Aβ-induced synaptic damage and neurotoxicity (Rapoport et al., 2002; Nussbaum et al., 2012; Zempel et al., 2013) or to Aβ-induced defects in axonal transport (Vossel et al., 2011).”
From Wild-Type, but Not Mutant N296H, Human Tau Restores Aβ-Mediated Inhibition of LTP in Tau−/− mice (2017) · cites this paper as Rapoport et al., 2002
In the citing paper
“Neurons without tau are resistant to Aβ toxicity, and APP transgenic mice lacking tau develop Aβ pathology but remain cognitively normal (Rapoport et al., 2002; Roberson et al., 2007).”
From CIP2A Causes Tau/APP Phosphorylation, Synaptopathy, and Memory Deficits in Alzheimer’s Disease (2018) · cites this paper as Rapoport et al., 2002
In the citing paper
“Data from cell and animal models show that tau is also a mediator of Aβ-induced toxicity46–48.”
From Tau-targeting therapies for Alzheimer disease (2018) · cites this paper as [46]
Citations
Cites
PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
Lowry, O., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 317,331
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
LAEMMLI, U. K. (1970) · Nature · doi:10.1038/227680a0 · Cited by 249,961
Towbin, H., Staehelin, T., & Gordon, J. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.9.4350 · Cited by 53,385
Raza, H., John, A., & Nemmar, A. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350087 · Cited by 47,221
Glenner, G. G., & Wong, C. W. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(84)80190-4 · Cited by 5,404
Assay of proteins in the presence of interfering materials
Bensadoun, A., & Weinstein, D. (1976) · Analytical Biochemistry · doi:10.1016/s0003-2697(76)80064-4 · Cited by 3,179
Growth of a rat neuroblastoma cell line in serum-free supplemented medium.
Bottenstein, J. E., & Sato, G. H. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.1.514 · Cited by 2,276
Microtubule-associated protein tau. A component of Alzheimer paired helical filaments.
Grundke-Iqbal, I., Iqbal, K., Quinlan, M., Tung, Y. C., Zaidi, M. S., & Wisniewski, H. M. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)38495-8 · Cited by 1,778
Kosik, K. S., Joachim, C. L., & Selkoe, D. J. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.11.4044 · Cited by 1,459
Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red.
Lorenzo, A., & Yankner, B. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.25.12243 · Cited by 1,324
Research works printed but not linked: 2
- M P Vitek, C G Rasool, F de Sauvage, S M Vitek, R T Bartus, B Beer, R A Ashton, A F Macq, J M Maloteaux, A J Blume Brain Res 464, 121–131 (1988).
- J G Wood, S S Mirra, N L Pollock, L I Binder Proc Natl Acad Sci USA 508, 320–324 (1986).
Cited by
Items 301–400 of 971
Phosphorylated tau potentiates Aβ-induced mitochondrial damage in mature neurons
Quintanilla, R. A., Rommy von Bernhardi, M., Godoy, J. A., Inestrosa, N. C., & Johnson, G. V. W. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.08.016 · Cited by 75
Miyata, Y., Koren, J., Kiray, J., Dickey, C. A., & Gestwicki, J. E. (2011) · Future Medicinal Chemistry · doi:10.4155/fmc.11.88 · Cited by 74
Li, L., von Bergen, M., Mandelkow, E.-M., & Mandelkow, E. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206334200 · Cited by 74
Corsetti, V., Amadoro, G., Gentile, A., Capsoni, S., Ciotti, M. T., Cencioni, M. T., Atlante, A., Canu, N., Rohn, T. T., Cattaneo, A., et al. (2008) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2008.03.011 · Cited by 73
Mechanisms in dominant parkinsonism: The toxic triangle of LRRK2, α‐synuclein, and tau
Taymans, J., & Cookson, M. (2010) · BioEssays · doi:10.1002/bies.200900163 · Cited by 73
Chun, W., Waldo, G. S., & Johnson, G. V. W. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04941.x · Cited by 73
Yoshiyama, Y., Zhang, B., Bruce, J., Trojanowski, J. Q., & Lee, V. M.-Y. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-33-10662.2003 · Cited by 72
Association of Aβ with ceramide-enriched astrosomes mediates Aβ neurotoxicity
Elsherbini, A., Kirov, A. S., Dinkins, M. B., Wang, G., Qin, H., Zhu, Z., Tripathi, P., Crivelli, S. M., & Bieberich, E. (2020) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-00931-8 · Cited by 72
Harada, H., Tamaoka, A., Ishii, K., Shoji, S., Kametaka, S., Kametani, F., Saito, Y., & Murayama, S. (2005) · Neuroscience Research · doi:10.1016/j.neures.2005.10.001 · Cited by 72
Gerson, J. E., Castillo-Carranza, D. L., & Kayed, R. (2014) · ACS Chemical Neuroscience · doi:10.1021/cn500143n · Cited by 72
Wallin, C., Hiruma, Y., Wärmländer, S. K. T. S., Huvent, I., Jarvet, J., Abrahams, J. P., Gräslund, A., Lippens, G. M., & Luo, J. (2018) · Journal of the American Chemical Society · doi:10.1021/jacs.7b13623 · Cited by 72
HDAC6 and RhoA are novel players in Abeta-driven disruption of neuronal polarity
Tsushima, H., Emanuele, M., Polenghi, A., Esposito, A., Vassalli, M., Barberis, A., Difato, F., & Chieregatti, E. (2015) · Nature Communications · doi:10.1038/ncomms8781 · Cited by 71
Perivascular spaces as a potential biomarker of Alzheimer’s disease
Lynch, M., Pham, W., Sinclair, B., O'Brien, T. J., Law, M., & Vivash, L. E. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.1021131 · Cited by 71
Li, G., Faibushevich, A., Turunen, B. J., Yoon, S. O., Georg, G., Michaelis, M. L., & Dobrowsky, R. T. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01526.x · Cited by 71
Ramser, E. M., Gan, K. J., Decker, H., Fan, E. Y., Suzuki, M. M., Ferreira, S. T., & Silverman, M. A. (2013) · Molecular Biology of the Cell · doi:10.1091/mbc.e12-12-0858 · Cited by 71
Physiological and Pathophysiological Implications of Synaptic Tau
Regan, P., Whitcomb, D. J., & Cho, K. (2017) · The Neuroscientist · doi:10.1177/1073858416633439 · Cited by 71
Canu, N., Amadoro, G., Triaca, V., Latina, V., Sposato, V., Corsetti, V., Severini, C., Ciotti, M. T., & Calissano, P. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18061319 · Cited by 71
Aβ, tau and ApoE4 in Alzheimer's disease: the axonal connection
Adalbert, R., Gilley, J., & Coleman, M. P. (2007) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2007.02.004 · Cited by 69
Beta-Amyloid and Tau-Protein: Structure, Interaction, and Prion-Like Properties
Tatarnikova, O. G., Орлов, М. А., & Bobkova, N. V. (2015) · Biochemistry (Moscow) · doi:10.1134/s000629791513012x · Cited by 69
Decreased sAβPPβ, Aβ 38 , and Aβ 40 Cerebrospinal Fluid Levels in Frontotemporal Dementia
Gabelle, A., Roche, S., Gény, C., Bennys, K., Labauge, P., Tholance, Y., Quadrio, I., Tiers, L., Gor, B., Boulanghien, J., et al. (2011) · Journal of Alzheimer’s Disease · doi:10.3233/jad-2011-110515 · Cited by 68
Tau Immunotherapies for Alzheimer’s Disease and Related Tauopathies: Progress and Potential Pitfalls
Sigurdsson, E. M. (2018) · Journal of Alzheimer's Disease · doi:10.3233/jad-189010 · Cited by 67
Role of GSK‐3β activation and α7 nAChRs in Aβ1–42‐induced tau phosphorylation in PC12 cells
Hu, M., Waring, J. F., Gopalakrishnan, M., & Li, J. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05483.x · Cited by 67
Li, X., Lei, P., Tuo, Q., Ayton, S., Li, Q., Moon, S., Volitakis, I., Liu, R., Masters, C. L., Finkelstein, D. I., et al. (2015) · Neurotherapeutics · doi:10.1007/s13311-015-0378-2 · Cited by 67
Cofilin, a Master Node Regulating Cytoskeletal Pathogenesis in Alzheimer’s Disease
Kang, D. E., & Woo, J. A. (2019) · Journal of Alzheimer's Disease · doi:10.3233/jad-190585 · Cited by 67
Lopes, S., Teplytska, L., Vaz-Silva, J., Dioli, C., Trindade, R., Morais, M., Webhofer, C., Maccarrone, G., Almeida, O. F. X., Turck, C. W., et al. (2016) · Cerebral Cortex · doi:10.1093/cercor/bhw057 · Cited by 66
Tau and Membranes: Interactions That Promote Folding and Condensation
Sallaberry, C. A., Voss, B. J., Majewski, J. P., Biernat, J., Mandelkow�, E., Chi, E. Y., & Zanden, C. M. V. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.725241 · Cited by 66
Zhu, Y., & Wang, J. (2015) · Neurological Sciences · doi:10.1007/s10072-015-2070-z · Cited by 66
Hyperphosphorylated Tau is Elevated in Alzheimer's Disease with Psychosis
Murray, P. S., Kirkwood, C. M., Gray, M. C., Fish, K. N., Ikonomovic, M. D., Hamilton, R. L., Kofler, J. K., Klunk, W. E., Lopez, O. L., & Sweet, R. A. (2014) · Journal of Alzheimer's Disease · doi:10.3233/jad-131166 · Cited by 65
Alzheimer Aβ disrupts the mitotic spindle and directly inhibits mitotic microtubule motors
Borysov, S. I., Granic, A., Padmanabhan, J., Walczak, C., & Potter, H. (2011) · Cell Cycle · doi:10.4161/cc.10.9.15478 · Cited by 65
Immune and myodegenerative pathomechanisms in inclusion body myositis
Keller, C. W., Schmidt, J., & Lünemann, J. D. (2017) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.419 · Cited by 65
Role of cdk5 in the Pathogenesis of Alzheimer’s Disease
Lau, L., & Ahlijanian, M. K. (2003) · Neurosignals · doi:10.1159/000074622 · Cited by 65
β-Amyloid Induces Pathology-Related Patterns of Tau Hyperphosphorylation at Synaptic Terminals
Wu, H.-Y., Kuo, P.-C., Wang, Y.-T., Lin, H.-T., Roe, A. D., Wang, B. Y., Han, C.-L., Hyman, B. T., Chen, Y.-J., & Tai, H.-C. (2018) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nly059 · Cited by 64
Formation of Phospho-SAPK/JNK Granules in the Hippocampus Is an Early Event in Alzheimer Disease
Lagalwar, S., Guillozet-Bongaarts, A. L., Berry, R. W., & Binder, L. I. (2006) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/01.jnen.0000229236.98124.d8 · Cited by 64
Self-citationPeng, Y., Xing, C., Xu, S., Lemere, C. A., Chen, G., Liu, B., Wang, L., Feng, Y., & Wang, X. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.08.036 · Cited by 63
Hydrophobic tagging-mediated degradation of Alzheimer's disease related Tau
Gao, N., Chu, T.-T., Li, Q.-Q., Lim, Y.-J., Qiu, T., Ma, M.-R., Hu, Z.-W., Yang, X.-F., Chen, Y.-X., Zhao, Y.-F., et al. (2017) · RSC Advances · doi:10.1039/c7ra05347a · Cited by 62
Lee, S., Kim, W., Li, Z., & Hall, G. F. (2012) · International Journal of Alzheimer's Disease · doi:10.1155/2012/172837 · Cited by 62
Niewidok, B., Igaev, M., Sündermann, F., Janning, D., Bakota, L., & Brandt, R. (2016) · Molecular Biology of the Cell · doi:10.1091/mbc.e16-06-0402 · Cited by 62
Calpain Dysregulation in Alzheimer’s Disease
Ferreira, A. (2012) · ISRN Biochemistry · doi:10.5402/2012/728571 · Cited by 62
Self-citationJohnson, G. V. W., & Bailey, C. D. C. (2002) · Journal of Alzheimer's Disease · doi:10.3233/jad-2002-4505 · Cited by 61
Alzheimer disease: modeling an Aβ-centered biological network
Campion, D., Pottier, C. P., Nicolas, G., Guennec, K. L., & Rovelet‐Lecrux, A. (2016) · Molecular Psychiatry · doi:10.1038/mp.2016.38 · Cited by 61
Ramachandran, G., & Udgaonkar, J. B. (2013) · Biochemistry · doi:10.1021/bi400209z · Cited by 61
The Role of Mitochondrial Impairment in Alzheimer´s Disease Neurodegeneration: The Tau Connection
Quntanilla, R. A., & Tapia-Monsalves, C. (2020) · Current Neuropharmacology · doi:10.2174/1570159x18666200525020259 · Cited by 61
Bidirectional interplay of HSF1 degradation and UPR activation promotes tau hyperphosphorylation
Kim, E., Sakata, K., & Liao, F. (2017) · PLoS Genetics · doi:10.1371/journal.pgen.1006849 · Cited by 60
Tangles, Toxicity, and Tau Secretion in AD – New Approaches to a Vexing Problem
Gendreau, K. L., & Hall, G. F. (2013) · Frontiers in Neurology · doi:10.3389/fneur.2013.00160 · Cited by 60
Sialometabolism in Brain Health and Alzheimer’s Disease
Rawal, P., & Zhao, L. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.648617 · Cited by 60
Okuda, M., Fujita, Y., Hijikuro, I., Wada, M., Uemura, T., Kobayashi, Y., Waku, T., Tanaka, N., Nishimoto, T., Izumi, Y., et al. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-161017 · Cited by 60
Neurotrophin receptor p75 mediates amyloid β-induced tau pathology
Shen, L.-L., Li, W.-W., Xu, Y.-L., Gao, S.-H., Xu, M.-Y., Bu, X.-L., Liu, Y.-H., Wang, J., Zhu, J., Zeng, F., et al. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104567 · Cited by 59
“Abundant evidence suggests that tau phosphorylation is downstream of Aβ (Bolmont et al., 2007; Busciglio et al., 1995; Geula et al., 1998; Gotz et al., 2001b; Hoerndli et al., 2007) and that tau mediates Aβ toxicity in AD (Haass and Mandelkow, 2010; Ittner et al., 2010; Rapoport et al., 2002).”
BackgroundIntracellular and extracellular tau
Avila, J. (2010) · Frontiers in Neuroscience · doi:10.3389/fnins.2010.00049 · Cited by 59
Stabilization of dynamic microtubules by mDia1 drives Tau-dependent Aβ1–42 synaptotoxicity
Qu, X., Yuan, F. N., Corona, C., Pasini, S., Pero, M. E., Gundersen, G. G., Shelanski, M. L., & Bartolini, F. (2017) · Journal of Cell Biology · doi:10.1083/jcb.201701045 · Cited by 59
Differences Between Human and Murine Tau at the N-terminal End
Hernández, F., Merchán-Rubira, J., Vallés-Saiz, L., Rodríguez-Matellán, A., & Avila, J. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.00011 · Cited by 58
The potential role of nutritional components in the management of Alzheimer's Disease
van der Beek, E. M., & Kamphuis, P. J. G. H. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.01.049 · Cited by 58
Tau Mediated Neurodegeneration: An Insight into Alzheimer’s Disease Pathology
Obulesu, M., Venu, R., & Somashekhar, R. (2011) · Neurochemical Research · doi:10.1007/s11064-011-0475-5 · Cited by 58
GSK-3β Directly Phosphorylates and Activates MARK2/PAR-1
Kosuga, S., Tashiro, E., Kajioka, T., Ueki, M., Shimizu, Y., & Imoto, M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m507941200 · Cited by 57
Coşacak, M. İ., Bhattarai, P., Bocova, L., Dzewas, T., Mashkaryan, V., Papadimitriou, C., Brandt, K., Hollak, H., Antos, C. L., & Kızıl, Ç. (2017) · Scientific Reports · doi:10.1038/s41598-017-13311-5 · Cited by 57
Leschik, J., Welzel, A., Weissmann, C., Eckert, A., & Brandt, R. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04435.x · Cited by 56
Tau Reduction Does Not Prevent Motor Deficits in Two Mouse Models of Parkinson's Disease
Morris, M., Koyama, A., Masliah, E., & Mucke, L. (2011) · PLoS ONE · doi:10.1371/journal.pone.0029257 · Cited by 56
Modi, K. K., Jana, A., Ghosh, S., Watson, R. L., & Pahan, K. (2014) · PLoS ONE · doi:10.1371/journal.pone.0103606 · Cited by 56
The Handbook of Neuropsychiatric Biomarkers, Endophenotypes and Genes
Ritsner, M. S. (2009) · Springer eBooks · doi:10.1007/978-1-4020-9464-4 · Cited by 55
Brain-Derived Neurotrophic Factor: the Link Between Amyloid-β and Memory Loss
Fahnestock, M. (2011) · Future Neurology · doi:10.2217/fnl.11.44 · Cited by 55
Ling, K., Hewitt, C., Beißbarth, T., Hyde, L., Banerjee, K., Cheah, P.-S., Cannon, P., Hahn, C. N., Thomas, P. Q., Smyth, G. K., et al. (2009) · Genome biology · doi:10.1186/gb-2009-10-10-r104 · Cited by 55
Haense, C., Buerger, K., Kalbe, E., Drzezga, A., Teipel, S. J., Markiewicz, P., Herholz, K., Heiss, W. D., & Hampel, H. (2008) · European Journal of Neurology · doi:10.1111/j.1468-1331.2008.02274.x · Cited by 55
Velasco, P. T., Heffern, M. C., Sebollela, A., Popova, I. A., Lacor, P. N., Lee, K. B., Sun, X., Tiano, B. N., Viola, K. L., Eckermann, A. L., et al. (2012) · ACS Chemical Neuroscience · doi:10.1021/cn300122k · Cited by 55
Contribution of neural networks to Alzheimer disease's progression
Savioz, A., Leuba, G., Vallet, P. G., & Walzer, C. (2009) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2009.06.006 · Cited by 55
Recent Advances in Targeting Transition Metals (Copper, Iron, and Zinc) in Alzheimer’s Disease
Singh, R., Panghal, A., Jadhav, K., Thakur, A., Verma, R. K., Singh, C., Goyal, M., Kumar, J., & Namdeo, A. G. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04256-8 · Cited by 55
Hashem, J., Hu, M., Zhang, J., Gao, F., & Chen, C. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02400-2 · Cited by 55
Serdons, K., Verduyckt, T., Cleynhens, J., Terwinghe, C. Y., Mortelmans, L., Bormans, G. M., & Verbruggen, A. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.09.055 · Cited by 55
Rebeck, G. W., Hoe, H.-S., & Moussa, C. E.-H. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.083915 · Cited by 54
Prefibrillar Tau Oligomers in Mild Cognitive Impairment and Alzheimer's Disease
Mufson, E. J., Ward, S., & Binder, L. (2014) · Neurodegenerative Diseases · doi:10.1159/000353687 · Cited by 54
Self-citationRole of Liver X Receptor in AD Pathophysiology
Sandoval-Hernández, A. G., Buitrago, L., Moreno, H., Cardona-Gómez, G. P., & Arboleda, G. (2015) · PLOS ONE · doi:10.1371/journal.pone.0145467 · Cited by 54
Interdisciplinary challenges and promising theranostic effects of nanoscience in Alzheimer's disease
Laurent, S., Ejtehadi, M. R., Rezaei, M., Kehoe, P. G., & Mahmoudi, M. (2012) · RSC Advances · doi:10.1039/c2ra01374f · Cited by 54
Karima, O., Riazi, G. H., Yousefi, R., & Moosavi‐Movahedi, A. A. (2010) · Neurological Sciences · doi:10.1007/s10072-010-0220-x · Cited by 54
Zhang, B., Li, Q., Chu, X., Sun, S., & Chen, S. (2016) · Translational Neurodegeneration · doi:10.1186/s40035-016-0068-y · Cited by 54
Rangasamy, S. B., Corbett, G. T., Roy, A., Modi, K. K., Bennett, D. A., Mufson, E. J., Ghosh, S., & Pahan, K. (2015) · Journal of Alzheimer's Disease · doi:10.3233/jad-150040 · Cited by 53
Role of Trisomy 21 Mosaicism in Sporadic and Familial Alzheimer's Disease
Potter, H., Granic, A., & Caneus, J. (2015) · Current Alzheimer Research · doi:10.2174/156720501301151207100616 · Cited by 53
Romero, A. M., Esteban-Pretel, G., Marín, M. P., Ponsoda, X., Ballestín, R., Canales, J. J., & Renau‐Piqueras, J. (2010) · Toxicological Sciences · doi:10.1093/toxsci/kfq260 · Cited by 53
Lu, Y., Li, T., Qureshi, H. Y., Han, D., & Paudel, H. K. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.220962 · Cited by 53
Opportunities and challenges in developing Alzheimer disease therapeutics
Iqbal, K., & Grundke, I. (2011) · Acta Neuropathologica · doi:10.1007/s00401-011-0878-z · Cited by 51
Wen, M., Xu, J., Ding, L., Zhang, L., Du, L., Wang, J., Wang, Y., & Xue, C. (2016) · Journal of Functional Foods · doi:10.1016/j.jff.2016.04.034 · Cited by 50
An update on the toxicity of Aβ in Alzheimer’s disease
Götz, J., Ittner, L. M., Schönrock, N., & Cappai, R. (2008) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s3016 · Cited by 50
Lerchundi, R., Neira, R., Valdivia, S., Vio, K., Concha, M. I., Zambrano, A., & Otth, C. (2011) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-101386 · Cited by 50
Kou, X., Chen, D., & Chen, N. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20071591 · Cited by 50
Slater, C. L., & Wang, Q. (2021) · Clinical and Translational Medicine · doi:10.1002/ctm2.397 · Cited by 50
Yan, Y., Yan, H., Teng, Y., Wang, Q., Yang, P., Zhang, L., Cheng, H., & Fu, S. (2020) · The Journal of Gene Medicine · doi:10.1002/jgm.3268 · Cited by 50
Truong, A. P., Tóth, G., Probst, G. D., Sealy, J. M., Bowers, S., Wone, D. W. G., Dressen, D. B., Hom, R. K., Konradi, A. W., Sham, H. L., et al. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.08.102 · Cited by 50
Kam, T.-I., Park, H., Gwon, Y., Song, S., Kim, S.-H., Moon, S. W., Jo, D.-G., & Jung, Y.-K. (2016) · eLife · doi:10.7554/elife.18691 · Cited by 49
Ari, C., Borysov, S. I., Wu, J., Padmanabhan, J., & Potter, H. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.02.006 · Cited by 49
CSF Tau Levels Influence Cortical Plasticity in Alzheimer's Disease Patients
Koch, G., Esposito, Z., Kusayanagi, H., Monteleone, F., Codecá, C., Di Lorenzo, F., Caltagirone, C., Bernardi, G., & Martorana, A. (2011) · Journal of Alzheimer's Disease · doi:10.3233/jad-2011-110116 · Cited by 49
Calió, M. L., Mosini, A. C., Marinho, D. S., Salles, G. N., Massinhani, F. H., Ko, G. M., & Porcionatto, M. A. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.105219 · Cited by 47
Sinjoanu, R. C., Kleinschmidt, S., Bitner, R. S., Brioni, J. D., Möller, A., & Ferreira, A. (2008) · Neurochemistry International · doi:10.1016/j.neuint.2008.06.003 · Cited by 46
Self-citationLithium down-regulates tau in cultured cortical neurons: A possible mechanism of neuroprotection
Rametti‐Lacroux, A., Esclaire, F., Yardin, C., Cogné, N., & Terro, F. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2008.01.034 · Cited by 46
An effective treatment for Alzheimer's disease must consider both amyloid and tau
Lansdall, C. J. (2014) · Bioscience Horizons · doi:10.1093/biohorizons/hzu002 · Cited by 46
Enhanced tau pathology via RanBP9 and Hsp90/Hsc70 chaperone complexes
Woo, J. A., Liu, T., Zhao, X., Trotter, C., Yrigoin, K., Cazzaro, S., Narvaez, E. D., Khan, H., Witas, R., Bukhari, A., et al. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx284 · Cited by 46
Tau is required for the function of extrasynaptic NMDA receptors
Pallas-Bazarra, N., Draffin, J., Cuadros, R., Antonio Esteban, J., & Avila, J. (2019) · Scientific Reports · doi:10.1038/s41598-019-45547-8 · Cited by 46
Tau as the Converging Protein between Chronic Stress and Alzheimer's Disease Synaptic Pathology
Sotiropoulos, I., & Sousa, N. (2015) · Neurodegenerative Diseases · doi:10.1159/000440844 · Cited by 46
NMDA receptor C-terminal signaling in development, plasticity, and disease
Hardingham, G. E. (2019) · F1000Research · doi:10.12688/f1000research.19925.1 · Cited by 46
Yeast as a Model System to Study Tau Biology
Vos, A. D., Anandhakumar, J., den Brande, J. V., Verduyckt, M., Franssens, V., Winderickx, J., & Swinnen, E. (2011) · International Journal of Alzheimer s Disease · doi:10.4061/2011/428970 · Cited by 45
Chiu, M., & Fan, L. (2014) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s45143 · Cited by 45
Tackenberg, C., Kulic, L., & Nitsch, R. M. (2020) · PLoS ONE · doi:10.1371/journal.pone.0239584 · Cited by 45
Romeo, M. A., Montani, M. S. G., Gaeta, A., D’Orazi, G., Faggioni, A., & Cirone, M. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2019.165647 · Cited by 44
Advances in tau-based drug discovery
Noble, W., Pooler, A. M., & Hanger, D. P. (2011) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2011.586690 · Cited by 44
Metadata
- Authors
- Rapoport, M., Dawson, H. N., Binder, L. I., Vitek, M. P., & Ferreira, A.
- Affiliations
- Northwestern University (US)
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2002-04-16
- Volume
- 99
- Issue
- 9
- Pages
- 6364-6369
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC122954
- OpenAlex
- W2081768153
- Cited by
- 807
- References
- 45
- Citations by year
- 2026: 10 · 2025: 19 · 2024: 22 · 2023: 24 · 2022: 22 · 2021: 25 · 2020: 44 · 2019: 37 · 2018: 40 · 2017: 43 · 2016: 39 · 2015: 40 · 2014: 55 · 2013: 44 · 2012: 51
- FWCI
- 15.19
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01ag015383-02)
- National Institute on Aging (AG15383)
- National Institute of Neurological Disorders and Stroke (R01NS039080, NS 39080)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- tau protein, amyloid-beta, Alzheimer's disease, neurotoxicity, neurite degeneration, hippocampal neurons, microtubules, cytoskeleton, amyloid plaques, neurofibrillary tangles, amyloid fibrils
- MeSH terms
- Animals, Brain, Central Nervous System, Cytoskeleton, Hippocampus, Humans, Immunohistochemistry, Mice, Transgenic, Microtubules, Phenotype, Immunoblotting, Blotting, Western, Amyloid beta-Peptides, tau Proteins, Mice, Knockout, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.